Emanuele Nappi
Overview
Explore the profile of Emanuele Nappi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paoletti G, Nappi E, Bragato M, Valli P, Giovannini M, Gargano D, et al.
World Allergy Organ J
. 2025 Jan;
18(1):101015.
PMID: 39810828
Background: Allergen immunotherapy (AIT) is the only treatment that modifies the natural course of allergies. However, AIT is only used in some eligible patients, is frequently underused, and only a...
2.
Giombi F, Mercante G, Nappi E, Marzio V, Malvezzi L
Curr Opin Allergy Clin Immunol
. 2024 Dec;
PMID: 39705186
Purpose Of Review: Advances in understanding the molecular pathways underlying nasal epithelial inflammation have ushered in the era of personalized medicine for chronic rhinosinusitis with nasal polyps (CRSwNP). Research progress...
3.
Tonutti A, Motta F, Isailovic N, Ceribelli A, Ragusa R, Nappi E, et al.
RMD Open
. 2024 Sep;
10(3.
PMID: 39306344
Objective: Systemic sclerosis (SSc) is associated with an increased risk of cancer. We aimed to assess the prevalence of cancer in our cohort and to explore possible associations with clinical,...
4.
Scavello F, Brunetta E, Mapelli S, Nappi E, Garcia Martin I, Sironi M, et al.
EBioMedicine
. 2024 Sep;
108:105372.
PMID: 39299004
No abstract available.
5.
Scavello F, Brunetta E, Mapelli S, Nappi E, Garcia Martin I, Sironi M, et al.
EBioMedicine
. 2024 Jun;
105:105213.
PMID: 38908098
Background: COVID-19 clinical course is highly variable and secondary infections contribute to COVID-19 complexity. Early detection of secondary infections is clinically relevant for patient outcome. Procalcitonin (PCT) and C-reactive protein...
6.
Lamacchia D, Nappi E, Marzio V, Locatelli F, Messina M, Heffler E
Curr Opin Allergy Clin Immunol
. 2024 May;
24(4):257-265.
PMID: 38743499
Purpose Of Review: The aim of this review is to provide an account of the focus of therapeutic strategies for hereditary angioedema (HAE), give a brief overview of those used...
7.
Giombi F, Pace G, Nappi E, Giunta G, Muci G, Pirola F, et al.
Laryngoscope
. 2023 Dec;
134(6):2626-2633.
PMID: 38126613
Objective: To provide real-life evidence on long-term radiological changes in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) treated with dupilumab, and to assess possible differences between radiological and...
8.
Ferri S, Montagna C, Casini M, Malvezzi L, Pirola F, Russo E, et al.
Ann Allergy Asthma Immunol
. 2023 Aug;
132(1):69-75.
PMID: 37652235
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with a substantial burden on patients' quality of life and impaired sleep quality. The most common CRSwNP endotype is characterized by...
9.
Canonica G, Del Moro L, Costanzo G, Nappi E, Paoletti G
Asia Pac Allergy
. 2023 Jun;
13(1):40-43.
PMID: 37389100
Explanatory randomized controlled clinical trials test hypotheses to see if the intervention causes an outcome of interest in optimal circumstances, that is, established by selecting patients based on inclusion and...
10.
Costanzo G, Costanzo G, Del Moro L, Nappi E, Pelaia C, Puggioni F, et al.
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298721
Mast cells (MCs) are fascinating cells of the innate immune system involved not only in allergic reaction but also in tissue homeostasis, response to infection, wound healing, protection against kidney...